The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled ``Product Development in Hemophilia.'' The purpose of the public workshop is to discuss issues related to development and regulation of novel hemophilia products.
Document
Product Development in Hemophilia; Public Workshop
The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled ``Product Development in Hemophilia.'' The purpose of the public w...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
83 FR 55188
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Product Development in Hemophilia; Public Workshop,” thefederalregister.org (November 2, 2018), https://thefederalregister.org/documents/2018-23947/product-development-in-hemophilia-public-workshop.